SEC Sues InterMune Options Buyers Over Inside Tips

By Christie Smythe · December 23, 2010, 6:35 PM EST

The U.S. Securities and Exchange Commission has filed suit against unknown InterMune Inc. stock options purchasers, contending that they may have profited from inside information about the biotechnology company's lung disease...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Recent Articles By Christie

July 28, 2011
Ex-Hospital Admins Face 2 Trials In Kickbacks Case
July 26, 2011
US Airs Disgraced Pol's Calls In Hospital Bribe Trial
July 11, 2011
Ex-Teva Scientist Testifies In Copaxone Patent Battle
July 08, 2011
Alleged Gangster Cops Plea In $100M Medicare Fraud Case
June 27, 2011
New Charges Coming In Hospital Bribery Case, Feds Say
April 29, 2011
Ex-Hospital Exec Gets Bench Trial In Bribery Case
April 14, 2011
UBS Urges 2nd Circ. To Nix Hospital Co.'s ARS Win
April 13, 2011
Feds Charge FrontPoint Trader In $30M Inside Tips Case
March 18, 2011
Convicted Trader Protests SEC Penalty In 2nd Circ.
February 15, 2011
Quigley To Meet Deadline Or Face Asbestos Claims